MedPath

金日制药（中国）有限公司

Ownership
-
Established
1991-07-05
Employees
-
Market Cap
-
Website
www.jr66.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

59

NMPA:59

Drug Approvals

Norfloxacin Capsules

Product Name
诺氟沙星胶囊
Approval Number
国药准字H35020331
Approval Date
Oct 12, 2024
NMPA

Cefalexin Capsules

Product Name
头孢氨苄胶囊
Approval Number
国药准字H35020329
Approval Date
Oct 12, 2024
NMPA

Cefalexin Cranules

Product Name
头孢氨苄颗粒
Approval Number
国药准字H35020332
Approval Date
Oct 12, 2024
NMPA

Acetylspiramycin Capsules

Product Name
乙酰螺旋霉素胶囊
Approval Number
国药准字H35020334
Approval Date
Oct 12, 2024
NMPA

Cefixime Capsules

Product Name
头孢克肟胶囊
Approval Number
国药准字H20050647
Approval Date
Oct 12, 2024
NMPA

Cefradine Granules

Product Name
头孢拉定颗粒
Approval Number
国药准字H35020333
Approval Date
Oct 12, 2024
NMPA

Cefradine Capsules

Product Name
头孢拉定胶囊
Approval Number
国药准字H35020330
Approval Date
Oct 12, 2024
NMPA

Clarithromycin Dispersible Tablets

Product Name
盈博顿
Approval Number
国药准字H19991030
Approval Date
Sep 26, 2024
NMPA

Clarithromycin Dispersible Tablets

Product Name
盈博顿
Approval Number
国药准字H19991029
Approval Date
Sep 26, 2024
NMPA

Metronidazole Tablets

Product Name
甲硝唑片
Approval Number
国药准字H20003083
Approval Date
Sep 26, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy